Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes

M. Pepe (Munich, Germany), F. Pelizza (Glascow, United Kingdom), A. Lamort (Munich, Germany), N. Kanellakis (Patras, Greece), G. Stathopoulos (Munich, Germany)

Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Session: Lung cancer: from the bench to the bedside
Session type: Thematic Poster
Number: 2841
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Pepe (Munich, Germany), F. Pelizza (Glascow, United Kingdom), A. Lamort (Munich, Germany), N. Kanellakis (Patras, Greece), G. Stathopoulos (Munich, Germany). Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes. 2841

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017

Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020

Influence of smoking on gene expression in lung adenocarcinoma
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009



Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Identification of differentially expressed genes in squamous cell carcinoma of the lung using differential display
Source: Eur Respir J 2005; 26: Suppl. 49, 457s
Year: 2005

Identification of membrane-associated proteins as new candidate biomarkers of small-cell lung cancer
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010

Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005

PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: ERS Lung Science Conference 2021
Year: 2021

Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012

Mapping of Kras mutations during chemical carcinogenesis
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


PP134 – Mapping of Kras mutations during chemical carcinogenesis
Source: ERS Lung Science Conference 2021
Year: 2021

Epigenetic inactivation of checkpoint kinase 2 gene in nonsmall cell lung cancer and its relationship with clinicopathological features
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Tumoural tissue specific promoter hypermethylation of distinct tumour suppressor genes in a case with nonsmall cell lung carcinoma: a case report
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009